亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。
Selective HDAC6 Inhibitor for the treatment of Alzheimer's and related diseases
總結
Ronald Breslow, Ph.D.
技術優勢
Compounds target HDAC6 with 100-fold selectivity over HDAC1.Specific and selective inhibition of HDAC6 offers a therapy for the treatment of Alzheimer's and other neurological diseases while potentially minimizing off-target toxicities caused by pan-HDAC inhibitors. Patent information:Patent Pending (WO/2011/46855)Tech Ventures Reference: IR M10-078
技術應用
Treatment of Alzheimer's disease through specific HDAC6 inhibition.Potentially useful for other central nervous system diseases such as Parkinson's and Huntington's.
詳細技術說明
Ronald Breslow, Ph.D.
國家/地區
美國
欲了解更多信息，請點擊 這裡
